A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis. - Pandey​, Krishna; Pal, Biplab; Siddiqui, Niyamat Ali; Lal, Chandra Shekhar; Ali, Vahab; Bimal, Sanjiva; Kumar, Ashish; Verma, Neena; Rabi Das, Vidya Nand; Singh, Shubhankar Kumar; Topno, Roshan Kamal; Das, Pradeep; et al. (Indian Journal of Dermatology, Venereology & Leprology, 2021)